首页> 外文期刊>Breast cancer research and treatment. >Family history of breast cancer and all-cause mortality after breast cancer diagnosis in the Breast Cancer Family Registry
【24h】

Family history of breast cancer and all-cause mortality after breast cancer diagnosis in the Breast Cancer Family Registry

机译:乳腺癌家族病史和乳腺癌家庭注册中乳腺癌诊断后的全因死亡率

获取原文
获取原文并翻译 | 示例
           

摘要

Although having a family history of breast cancer is a well established breast cancer risk factor, it is not known whether it influences mortality after breast cancer diagnosis. We studied 4,153 women with first primary incident invasive breast cancer diagnosed between 1991 and 2000, and enrolled in the Breast Cancer Family Registry through population-based sampling in Northern California, USA; Ontario, Canada; and Melbourne and Sydney, Australia. Cases were oversampled for younger age at diagnosis and/or family history of breast cancer. Carriers of germline mutations in BRCA1 or BRCA2 were excluded. Cases and their relatives completed structuredquestionnaires assessing breast cancer risk factors and family history of cancer. Cases were followed for a median of 6.5 years, during which 725 deaths occurred. Cox proportional hazards regression was used to evaluate associations between family history of breast cancer at the time of diagnosis and risk of all-cause mortality after breast cancer diagnosis, adjusting for established prognostic factors. The hazard ratios for all-cause mortality were 0.98 (95% confidence interval [CI] = 0.84-1.15) for having at least one first- or second-degree relative with breast cancer, and 0.85 (95% CI = 0.70-1.02) for having at least one first-degree relative with breast cancer, compared with having no such family history. Estimates did not vary appreciably when stratified by case or tumor characteristics. In conclusion, family history of breast cancer is not associated with all-cause mortality after breast cancer diagnosis for women without a known germline mutation in BRCA1 or BRCA2. Therefore, clinical management should not depend on family history of breast cancer.
机译:尽管具有乳腺癌家族史是公认的乳腺癌危险因素,但尚不清楚其是否影响乳腺癌诊断后的死亡率。我们研究了4153名在1991年至2000年之间被诊断为首次原发性浸润性乳腺癌的妇女,并通过在美国北加州进行的基于人群的抽样研究将其纳入了乳腺癌家庭登记处。加拿大安大略省;以及澳大利亚的墨尔本和悉尼。在乳腺癌的诊断和/或家族史中,对年龄过小的病例进行了抽样调查。排除BRCA1或BRCA2中种系突变的携带者。病例及其亲属完成了结构化问卷,以评估乳腺癌危险因素和癌症家族史。病例追踪的平均时间为6.5年,其中725例死亡。使用Cox比例风险回归来评估诊断时的乳腺癌家族史与乳腺癌诊断后全因死亡率风险之间的关联,并调整已建立的预后因素。具有至少一个一级或二级亲属乳腺癌的全因死亡率的危险比是0.98(95%置信区间[CI] = 0.84-1.15),是0.85(95%CI = 0.70-1.02)与没有这样的家族病史相比,至少有一个一级亲戚患有乳腺癌。按病例或肿瘤特征分层时,估计值没有明显变化。总之,对于没有已知BRCA1或BRCA2生殖系突变的女性,乳腺癌家族史与乳腺癌诊断后的全因死亡率无关。因此,临床管理不应依赖于乳腺癌家族史。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号